Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation

References

• Aldovini A, Feinberg M B. Techniques in HIV research. Stockton Press, New York 1990
   Google Scholar
• Andreoni M. Viral phenotype and fitness. New Microbiol 2004; 27: 71–76
   Google Scholar
• Bannwarth S, Gatignol A. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Curr HIV Res 2005; 3: 61–71
   PubMed Web of Science ®Google Scholar
• Biswas D K, Salas T R, Wang F, Ahlers C M, Dezube B J, Pardee A B. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J Virol 1995; 69: 7437–7444
   PubMed Web of Science ®Google Scholar
• Boven L A, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet H S. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999; 162: 4319–4327
   PubMedGoogle Scholar
• Boven L A, Vergnolle N, Henry S D, Silva C, Imai Y, Holden J, Warren K, Hollenberg M D, Power C. Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol 2003; 170: 2638–2646
   PubMed Web of Science ®Google Scholar
• Boykins R A, Mahieux R, Shankavaram U T, Gho Y S, Lee S F, Hewlett I K, Wahl L M, Kleinman H K, Brady J N, Yamada K M, Dhawan S. Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis. J Immunol 1999; 163: 15–20
   Google Scholar
• Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. Aids 1999; 13: 1–22
   PubMed Web of Science ®Google Scholar
• Bratanich A C, Liu C, McArthur J C, Fudyk T, Glass J D, Mittoo S, Klassen G A, Power C. Brain-derived HIV-1 tat sequences from AIDS patients with dementia show increased molecular heterogeneity. J Neurovirol 1998; 4: 387–393
   PubMed Web of Science ®Google Scholar
• Burdo T H, Nonnemacher M, Irish B P, Choi C H, Krebs F C, Gartner S, Wigdahl B. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. DNA Cell Biol 2004; 23: 261–269
   Google Scholar
• Chen P, Mayne M, Power C, Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. J Biol Chem 1997; 272: 22385–22388
   PubMed Web of Science ®Google Scholar
• Conant K, Garzino-Demo A, Nath A, McArthur J C, Halliday W, Power C, Gallo R C, Major E O. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998; 95: 3117–3121
   PubMed Web of Science ®Google Scholar
• Conant K, Ma M, Nath A, Major E O. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes. J Virol 1996; 70: 1384–1389
   PubMed Web of Science ®Google Scholar
• Darbinian N, Sawaya B E, Khalili K, Jaffe N, Wortman B, Giordano A, Amini S. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells. J Neuroimmunol 2001; 121: 3–11
   PubMed Web of Science ®Google Scholar
• Dayton A I, Sodroski J G, Rosen C A, Goh W C, Haseltine W A. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 1986; 44: 941–947
   PubMed Web of Science ®Google Scholar
• Gatignol A, Duarte M, Daviet L, Chang Y N, Jeang K T. Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors. Gene Expr 1996; 5: 217–228
   PubMedGoogle Scholar
• Genois N, Robichaud G A, Tremblay M J. Mono Mac 1: a new in vitro model system to study HIV-1 infection in human cells of the mononuclear phagocyte series. J Leukoc Biol 2000; 68: 854–864
   Google Scholar
• Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5: 69–81
   PubMed Web of Science ®Google Scholar
• Gorman C M, Moffat L F, Howard B H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 1044–1051
   PubMed Web of Science ®Google Scholar
• Hofman F M, Dohadwala M M, Wright A D, Hinton D R, Walker S M. Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 1994; 54: 19–28
   PubMed Web of Science ®Google Scholar
• Huigen M C, Kamp W, Nottet H S. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur J Clin Invest 2004; 34: 57–66
   PubMed Web of Science ®Google Scholar
• Johnston J B, Silva C, Gonzalez G, Holden J, Warren K G, Metz L M, Power C. Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis. Ann Neurol 2001a; 49: 650–658
   PubMedGoogle Scholar
• Johnston J B, Silva C, Holden J, Warren K G, Clark A W, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001b; 50: 434–442
   PubMed Web of Science ®Google Scholar
• Johnston J B, Zhang K, Silva C, Shalinsky D R, Conant K, Ni W, Corbett D, Yong V W, Power C. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol 2001c; 49: 230–241
   PubMed Web of Science ®Google Scholar
• Kelly G D, Morris C B, Offermann M K. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells. Virology 1999; 263: 128–138
   Google Scholar
• Lassen K, Han Y, Zhou Y, Siliciano J, Siliciano R F. The multifactorial nature of HIV-1 latency. Trends Mol Med 2004; 10: 525–531
   PubMed Web of Science ®Google Scholar
• Liu J, Blackhall F, Seiden-Long I, Jurisica I, Navab R, Liu N, Radulovich N, Wigle D, Sultan M, Hu J, Tsao M S, Johnston M R. Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis. Oncogene 2004; 23: 6316–6324
   Google Scholar
• Loregian A, Bortolozzo K, Boso S, Sapino B, Betti M, Biasolo M A, Caputo A, Palu G. The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein. J Cell Physiol 2003; 196: 251–257
   Google Scholar
• Marchio S, Alfano M, Primo L, Gramaglia D, Butini L, Gennero L, De Vivo E, Arap W, Giacca M, Pasqualini R, Bussolino F. Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein. Blood 2005; 105: 2802–2811
   PubMed Web of Science ®Google Scholar
• Mayne M, Bratanich A C, Chen P, Rana F, Nath A, Power C. HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease. Neuroimmunomodulation 1998; 5: 184–192
   PubMed Web of Science ®Google Scholar
• Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987; 326: 711–713
   PubMed Web of Science ®Google Scholar
• Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 2002; 186: S193–S198, Suppl 2
   PubMed Web of Science ®Google Scholar
• Nath A, Conant K, Chen P, Scott C, Major E O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol Chem 1999; 274: 17098–17102
   PubMed Web of Science ®Google Scholar
• Park E J, Kim J H, Seong R H, Kim C G, Park S D, Hong S H. Characterization of a novel mouse cDNA, ES18, involved in apoptotic cell death of T-cells. Nucleic Acids Res 1999; 27: 1524–1530
   Google Scholar
• Patel M, Yanagishita M, Roderiquez G, Bou-Habib D C, Oravecz T, Hascall V C, Norcross M A. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses 1993; 9: 167–174
   PubMed Web of Science ®Google Scholar
• Peruzzi F, Gordon J, Darbinian N, Amini S. Tat-induced deregulation of neuronal differentiation and survival by nerve growth factor pathway. J Neurovirol 2002; 2: 91–96, 8 Suppl
   Google Scholar
• Power C, Kong P A, Crawford T O, Wesselingh S, Glass J D, McArthur J C, Trapp B D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993; 34: 339–350
   PubMed Web of Science ®Google Scholar
• Power C, McArthur J C, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson R T, Chesebro B. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol 1998; 72: 9045–9053
   PubMed Web of Science ®Google Scholar
• Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 1999; 65: 458–465
   PubMed Web of Science ®Google Scholar
• Roof P, Ricci M, Genin P, Montano M A, Essex M, Wainberg M A, Gatignol A, Hiscott J. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 2002; 296: 77–83
   PubMed Web of Science ®Google Scholar
• Rossi A, Mukerjee R, Ferrante P, Khalili K, Amini S, Sawaya B E. Human immunodeficiency virus type 1 Tat prevents dephosphorylation of Sp1 by TCF-4 in astrocytes. J Gen Virol 2006; 87: 1613–1623
   Google Scholar
• Silva C, Zhang K, Tsutsui S, Holden J K, Gill M J, Power C. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Ann Neurol 2003; 54: 605–614
   PubMedGoogle Scholar
• Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong V W, Winston B W, Warren K, Power C. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 2004; 24: 1521–1529
   PubMed Web of Science ®Google Scholar
• van der Zee R, Anderton S M, Buskens C AF, Alonso de Velasco E, van Eden W. Heat shock protein T cell epitopes as immunogenic carriers in subunit vaccines. Twenty-third European peptide symposium, H LS Maya, Leiden 1994
   Google Scholar
• van Marle G, Power C. Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?. J Neurovirol 2005; 11: 107–128
   Google Scholar
• Wesselingh S L, Power C, Glass J D, Tyor W R, McArthur J C, Farber J M, Griffin J W, Griffin D E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993; 33: 576–582
   PubMedGoogle Scholar
• Zhang K, McQuibban G A, Silva C, Butler G S, Johnston J B, Holden J, Clark-Lewis I, Overall C M, Power C. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 2003a; 6: 1064–1071
   PubMed Web of Science ®Google Scholar
• Zhang K, Rana F, Silva C, Ethier J, Wehrly K, Chesebro B, Power C. Human immunodeficiency virus type 1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J Virol 2003b; 77: 6899–6912
   PubMed Web of Science ®Google Scholar